eMedicine Specialties > Pediatrics: General Medicine > Dermatology
Gianotti-Crosti Syndrome: Follow-up
Updated: Sep 29, 2008
Follow-up
Further Outpatient Care
- No specific follow-up is necessary for uncomplicated cases of Gianotti-Crosti syndrome (GCS); however, transaminase elevations, if present, should be monitored until normalization.
- GCS associated with hepatitis B infection has an increased incidence of a carrier state compared with hepatitis B infection alone. In this instance, some suggest monitoring the surface antigen as an indicator of potential infectivity.
Prognosis
- Prognosis is excellent. Lesions clear within 4-12 weeks. No long-term complications are associated with GCS.
Miscellaneous
Medicolegal Pitfalls
- No medical/legal pitfalls are associated with Gianotti-Crosti syndrome (GCS) because it is a self-limited condition that does not require treatment.
More on Gianotti-Crosti Syndrome |
| Overview: Gianotti-Crosti Syndrome |
| Differential Diagnoses & Workup: Gianotti-Crosti Syndrome |
| Treatment & Medication: Gianotti-Crosti Syndrome |
Follow-up: Gianotti-Crosti Syndrome |
| Multimedia: Gianotti-Crosti Syndrome |
| References |
| « Previous Page | Next Page » |
References
Baleviciene G, Maciuleviciene R, Schwartz RA. Papular acrodermatitis of childhood: the Gianotti-Crosti syndrome. Cutis. Apr 2001;67(4):291-4. [Medline].
Caputo R, Gelmetti C, Ermacora E, et al. Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. J Am Acad Dermatol. Feb 1992;26(2 Pt 1):207-10. [Medline].
Yoshida M, Tsuda N, Morihata T, et al. Five patients with localized facial eruptions associated with Gianotti-Crosti syndrome caused by primary Epstein-Barr virus infection. J Pediatr. Dec 2004;145(6):843-4. [Medline].
Mendoza N, Diamantis M, Arora A, et al. Mucocutaneous manifestations of Epstein-Barr virus infection. Am J Clin Dermatol. 2008;9(5):295-305. [Medline].
Draelos ZK, Hansen RC, James WD. Gianotti-Crosti syndrome associated with infections other than hepatitis B. JAMA. Nov 7 1986;256(17):2386-8. [Medline].
Brandt O, Abeck D, Gianotti R, Burgdorf W. Gianotti-Crosti syndrome. J Am Acad Dermatol. 2006;54:136-145. [Medline].
Chuh A, Lee A, Zawar V. The diagnostic criteria of Gianotti-Crosti syndrome: are they applicable to children in India?. Pediatr Dermatol. Sep-Oct 2004;21(5):542-7. [Medline].
Chuh AA. Diagnostic criteria for Gianotti-Crosti syndrome: a prospective case-control study for validity assessment. Cutis. Sep 2001;68(3):207-13. [Medline].
Magyarlaki M, Drobnitsch I, Schneider I. Papular acrodermatitis of childhood (Gianotti-Crosti disease). Pediatr Dermatol. Sep 1991;8(3):224-7. [Medline].
Taieb A, Plantin P, Du Pasquier P, et al. Gianotti-Crosti syndrome: a study of 26 cases. Br J Dermatol. Jul 1986;115(1):49-59. [Medline].
Further Reading
Keywords
Gianotti-Crosti syndrome, GCS, papular acrodermatitis of childhood, papulovesicular acrolocated syndrome, hepatitis B infection, hepatitis B, lymphadenopathy, rash Epstein-Barr virus, papular acrodermatitis, hepatosplenomegaly, inguinal adenopathy, rotavirus, cytomegalovirus, adenovirus, enterovirus, respiratory syncytial virus, parainfluenza virus, Parvovirus, paravaccinia, human herpesvirus 6, echovirus, molluscum contagiosum, human immunodeficiency virus, HIV, group A beta-hemolytic streptococci, Mycobacterium avium-intracellulare, Mycoplasma pneumoniae, Bartonella henselae, Borrelia burgdorferi, meningococcemia, polio, diphtheria, influenza, pertussis, measles, smallpox, hepatitis A
Follow-up: Gianotti-Crosti Syndrome